Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

First transmission of NDM bacteria between dog and human
This study is presumed to be the first in which researchers have shown the transmission of NDM-bacteria between dogs and humans.
Researchers isolate highly resistant strain from family dogs and owner

Researchers in Finland have reported the first-ever transmission of New Delhi metallo-beta-lactamase (NDM) bacteria between a dog and a human.

In 2015, NDM bacteria were identified in two Finnish dogs. Now, writing in the journal Eurosurveillance, Dr Thomas Grönthal and his team reveal that the owner of the dogs also carried the bacteria.

Dr Grönthal explains: “We were able, through the analysis of the genome of the bacteria, to conclude that the bacterial isolates from the dogs and humans were identical, which means that they were transmitted between dogs and humans.”

The study was a collaboration between the University of Helskini, the National Institute of Health and Welfare, and the Finish Food Safety Authority.

Researchers isolated a highly resistant NDM-5 producing bacterial strain from two family dogs and one of the family members. Both dogs and two members of the family also carried a multidrug-resistant ESBL bacterium.

The ESBL and the NDM bacterial strains researchers isolated from the humans and dogs were identical. However, the humans did not show any symptoms and the researchers were unable to identify the source of the NDM bacteria.

“We could not show with certainty in which direction the bacteria had transmitted, explains lead researcher Merja Rantala. “However, especially the NDM-bacteria probably moved from human to dog as these bacteria have not previously been identified in animals in Finland.”

“The use of carbapenem antibiotics in animals is prohibited in Finland, but the dogs had received numerous other antibiotics. This gave the NDM-bacteria a competitive edge and enabled them to persist in the dogs.”

This study is presumed to be the first in which researchers have shown the transmission of NDM-bacteria between dogs and humans. However, car­bapenemase-pro­du­cing bac­teria are becoming more common in animals.

Researchers recommend that laboratories investigating animal specimens should monitor the susceptibility of bacteria to carbapenems and extended-spectrum cephalosporins.

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.